4//SEC Filing
Hagan Joseph P 4
Accession 0000950170-24-062920
CIK 0001505512other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:21 PM ET
Size
5.3 KB
Accession
0000950170-24-062920
Insider Transaction Report
Form 4
Hagan Joseph P
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-20+990,000→ 990,000 totalExercise: $2.01Exp: 2034-05-19→ Common Stock (990,000 underlying)
Footnotes (1)
- [F1]The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.
Documents
Issuer
Regulus Therapeutics Inc.
CIK 0001505512
Entity typeother
Related Parties
1- filerCIK 0001465278
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:21 PM ET
- Size
- 5.3 KB